ENDECE LLC has a total of 66 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, Republic of Korea and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ADVANCE BIOFACTURES CORP, PURDUE PHARMA LTD and SUZHOU NEUPHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | Republic of Korea | 8 | |
#3 | Canada | 7 | |
#4 | EPO (European Patent Office) | 7 | |
#5 | Brazil | 6 | |
#6 | China | 6 | |
#7 | Mexico | 6 | |
#8 | United States | 6 | |
#9 | WIPO (World Intellectual Property Organization) | 6 | |
#10 | Singapore | 4 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Yarger James G | 44 |
#2 | Nye Steven H | 20 |
#3 | Yarger James | 12 |
#4 | Nye Steve | 8 |
#5 | James G Yarger | 6 |
#6 | Pariza Richard J | 6 |
#7 | Steven H Nye | 5 |
#8 | James Yarger | 3 |
Publication | Filing date | Title |
---|---|---|
US2021024568A1 | Methods for modulation of lipoprotein lipase and apolipoprotein c2 expression and/or activity in the treatment of peripheral and central nervous system tissue disease states | |
KR20160136363A | 6-substituted estradiol derivatives for the treatment of alzheimer's disease | |
WO2012129324A2 | 6-substituted estradiol derivatives for use in remyelination of nerve axons | |
MX2013002768A | 6-substituted demethyl-estradiol derivatives as er-beta agonists. | |
KR20120095461A | 6-substituted estradiol derivatives and methods of use | |
AU2009256237A1 | 6-substituted estradiol derivatives and methods of use | |
AU2007325092A1 | 6-alkoxyalkyl estradiol derivatives and methods of use | |
BRPI0616639A2 | (s) -6-methyloxaalkyl exemestane compounds and related methods of use |